- KR₩540bn
- KR₩626bn
- KR₩188bn
- 28
- 16
- 74
- 29
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.01 | ||
Price to Tang. Book | 4.46 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 2.88 | ||
EV to EBITDA | 31.59 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 0.71% | ||
Return on Equity | -0.03% | ||
Operating Margin | 2.23% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | 57,895.11 | 85,562.37 | 168,310 | 236,120.07 | 187,544.19 | 193,300 | n/a | 29.94% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | +627.23 | -37.5 | -98.06 | +3353.56 | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
GC Cell Corp formerly Green Cross Lab Cell Corp is a Korea-based company principally engaged in the provision of specimen testing services. The Company operates its business through four segments. The Specimen Testing Service segment provides sample testing services, clinical trial services, and veterinary testing services. The Cell Therapy segment is engaged in cell culture and technology transfer business. The Cord Blood Storage segment is engaged in the cord blood storage business. The Other Business segment is engaged in bio-logistics business and others.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- June 21st, 2011
- Public Since
- June 23rd, 2016
- No. of Shareholders
- 45,720
- No. of Employees
- 427
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 15,022,641
- Address
- 107, Ihyeon-ro 30beon-gil, Giheung-gu, YONGIN, 16924
- Web
- https://gccell.com/
- Phone
- +82 312609300
- Auditors
- Ernst & Young Han Young
Upcoming Events for 144510
Q2 2024 GC Cell Corp Earnings Release
Similar to 144510
DreamCIS
Korea Exchange - KOSDAQ
DT&CRO Co
Korea Exchange - KOSDAQ
IMBDX
Korea Exchange - KOSDAQ
Labgenomics Co
Korea Exchange - KOSDAQ
SLS Bio Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:09 UTC, shares in GC Cell are trading at KR₩35,950. This share price information is delayed by 15 minutes.
Shares in GC Cell last closed at KR₩35,950 and the price had moved by -16.82% over the past 365 days. In terms of relative price strength the GC Cell share price has underperformed the FTSE Developed Asia Pacific Index by -13.18% over the past year.
The overall consensus recommendation for GC Cell is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The GC Cell dividend yield is 0.28% based on the trailing twelve month period.
Last year, GC Cell paid a total dividend of KR₩100, and it currently has a trailing dividend yield of 0.28%. We do not have any data on when GC Cell is to next pay dividends.
We do not have data on when GC Cell is to next pay dividends. The historic dividend yield on GC Cell shares is currently 0.28%.
To buy shares in GC Cell you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩35,950, shares in GC Cell had a market capitalisation of KR₩540bn.
Here are the trading details for GC Cell:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 144510
Based on an overall assessment of its quality, value and momentum GC Cell is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like GC Cell. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +14.92%.
As of the last closing price of KR₩35,950, shares in GC Cell were trading -4.19% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The GC Cell PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩35,950.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
GC Cell's management team is headed by:
- Dae Wu Park - CEO